Home › Funds › Castleview Partners, LLC › BMY

Castleview Partners, LLC position in BMY

BRISTOL-MYERS SQUIBB CO · Health Care

Castleview Partners, LLC reported holding 88,876 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q3 2026 13F filing — a position valued at US$5.5M, representing 2.43% of its reported portfolio and ranking #6 among its reported holdings. Castleview Partners, LLC has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)88.88K sh
Reported value held$5.55M
Portfolio Weight2.43%
First reportedQ3 2023
Last changeAdd
Updated2026-10-10

Last updated: 2026-10-10 · Source: SEC EDGAR Form 13F-HR

How Castleview Partners, LLC's BMY position evolved

Castleview Partners, LLC first disclosed a stake in BMY in Q3 2023 at 2,060 shares (US$120K). The position peaked in Q3 2026 at 88,876 shares, worth US$5.5M. Across 13 filings, Castleview Partners, LLC increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 88,876 shares valued at US$5.5M — an increase of 5,350 shares quarter over quarter.. Notable position changes include a 48% increase in Q1 2024 (shares fell 23% over the following quarter), a 55% increase in Q2 2024 (shares rose 26% over the following quarter), a 766% increase in Q3 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.06K $119.56K New
Q4 2023 2.48K $127.36K Add
Q1 2024 3.68K $199.63K Add
Q2 2024 5.71K $237.18K Add
Q3 2024 49.44K $2.56M Add
Q4 2024 55.19K $3.13M Add
Q1 2025 67.90K $4.14M Add
Q2 2025 69.47K $3.22M Add
Q3 2025 74.04K $3.34M Add
Q4 2025 85.54K $4.61M Add
Q1 2026 73.99K $4.49M Reduce
Q2 2026 83.53K $4.81M Add
Q3 2026 88.88K $5.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMY and 13F data

BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 28 other funds we track also report a position in BMY — the largest reported positions include Banque Cantonale Vaudoise (US$7.85B), Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMY

All BMY fund holders →

FAQ

How long has Castleview Partners, LLC held BMY?

Castleview Partners, LLC has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Castleview Partners, LLC's current position in BMY?

As of Q3 2026, Castleview Partners, LLC holds 88.88K shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $5.55M, representing 2.43% of its reported portfolio and ranking #6.

Has Castleview Partners, LLC been buying or selling BMY?

In the latest 13F filing (Q3 2026), Castleview Partners, LLC increased its position in BMY. The position peaked in Q3 2026 at 88.88K shares.

Which other funds hold BMY?

Other major institutional holders of BMY include Banque Cantonale Vaudoise, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.